CD19 and paracoccidioidomycosis: Two out of 6 (2/6, 33%) MGUS cases with >90% CD19(-) plasma cells showed progression of disease, whereas none of the 26 (0/26, 0%) cases with <10% CD19(-) plasma cells evolved to PCM.